Work

Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial

Year: 2019

Type: article

Source: Journal of Affective Disorders

DOI: 10.1016/j.jad.2019.06.008

Authors: Jaimee L. Heffner, A. Eden Evins, Cristina Russ, David Lawrence, Catherine R. Ayers, Thomas McRae, Lisa St. Aubin, Alok Krishen, Robert West, Robert M. Anthenelli

Institutions: Fred Hutch Cancer Center, Harvard University, Massachusetts General Hospital, Pfizer (United States), University of California San Diego, University College London

Language: English

Topic: Smoking Behavior and Cessation

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, GlaxoSmithKline, Cancer Research UK, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Institute on Aging, National Institute on Drug Abuse

Awards: G1309605592, G1922367053, G477044821, Wearable Biosensors for Real-time Blood Alcohol Monitoring, Homeless Female Offenders Returning to the Community: Improving Hopeful Futures, Collaborative Study on the Genetics of Alcoholism (COGA)., National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)

OpenAlex ID: W2948176554

FWCI: 1.373

Cites: 34

Cited by: 23

Related to: 10